BUB1B and glioblastoma: Abnormal expression of BUB1 and BUB1B were resulted in the prognosis of patients with brain tumor [54], glioblastoma [55], colorectal cancer [56], and NSCLC [57], and resulted in the impairment of mitotic checkpoint function.